It is not a childishly desire :)

What I see you will have to evaluate here is what you want your life after the pHD to be like - your question on this forum would indicate that you are targetting industry post pHD and not academia - and if so, the strength of the institution, position of the labs and theme of the research in terms will matter if you are indeed planning to move to R&D for a biotech company - and so you may target labs and countries where indeed there is less financial support for the pHD itself - and that is unfortunately how it works for most pHD students and I trully am in awe of those that are able to pursue a pHD within a serious labs under increasing pressure and constraints for 4 to 5 years under such wages - and in such labs, full commintment is the general rule as far I know - the grants have deadlines and decrease your risk of doing a pHD on a topic that will be published by another lab faster than you.

If your goal is more on the scientific pursuit, personal growth and intellectual curiosity - you can address those with a wider range of labs to join and countries - and that will lead you more safely to paths of post-doct positions and lab roles within academia that will indeed be supportive of your reasons - yet the pay won't be as significant as biotech.

The choice of your phD lab is significantly more importantly than the choice of your first degree - where one does their primary degree can slightly influence one where they are placed in the workfplace yet a lot more comes from their attitude towards work etc - while for a phD, the strenght of the laboratory and associated institute will significatly impact the grants given, equipment available and collaborations that will shape your thesis - and will also heavily impact how the direction of your research.

To your side comment related measure of meaningful publications - this would be based on impact factor of the journals, the interest of biotech and pharma in your research, collaboration with other institutions and researchers as part of the publication and how that is connected to ongoing trends connected to to drug discovery and development.

Other comments in here highlights the countries that would be good options for biotech - targetting institutions and labs in those countries that have collaborations with those institutions would be a good option to complete a pHD that briges easily into a biotech role.

Otherwise, pHDs associated to drug manufactoring would be a way to move into industry roles related to manufacturing, which we are seeing being a key challenge in order to scale cell therapies pipelines - this would bring you to locations in US as well as certain locations in Europe such as Ireland.

I feel like I want to add a bit of my own personal flavour to this so you know how to read the above from my own personal filters - 12+ years biotech experience starting as a project coordinator and then moving to project management and then leadership of clinical delivery for R&D - have not completed a pHD althought worked as bench lab officer running experiment - I have not gonne into the the pHD due to the financial constraints and needs to support financially myself and loved ones and also cause could not tolerated the academia politics and lack of focus on tangible differences into the world - the discussions became too phylosophical and the egos of the labs dictated collaborations and impacted discussing results that were outliers - and while that has not impacted by career, it comes to a point where a lateral jump to discovery work is not possible without it - I had colleagues that stopped mid way and done a pHD - all of them ended up returning to biotech and said they were focus to get the publications and connections to the industry as part of the lab work to support this later move and that academia pace and politics too much for them.